Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19

被引：820
|
作者：
Ibarrondo, F. Javier [1 ]
Fulcher, Jennifer A. [1 ]
Yang, Otto O. [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 11期
基金：
美国国家卫生研究院;
关键词：
CORONAVIRUS;
D O I：
10.1056/NEJMc2025179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined with a mean half-life of approximately 36 days after recovery. Whether these results predict the duration of viral immunity in persons recovering from more severe cases of Covid-19 or those exposed to vaccines is unknown.
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [1] Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19 (vol 383, pg 1085, 2020)
    Ibarrondo, F. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (11): : E74 - E74
  • [2] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19
    Terpos, Evangelos
    Mentis, Andreas
    Dimopoulos, Meletios A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1695 - 1695
  • [3] Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19 REPLY
    Yang, Otto O.
    Ibarrondo, F. Javier
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17): : 1697 - 1698
  • [4] Elevated Levels of Cytotoxicity, Cytokines, and Anti-SARS-CoV-2 Antibodies in Mild Cases of COVID-19
    Fernandez-Rojas, Miguel A.
    Avila, Guillermina
    Romero-Valdovinos, Mirza
    Plett-Torres, Tanya
    Salazar, Ana Maria
    Sordo, Monserrat
    Chavez-Vargas, Mariana
    Angeles, Cesar Josue Coeto
    Cruz-Rivera, Mayra
    Santiago-Olivares, Carlos
    Hinojosa, Juan Pablo Ramirez
    Maravilla, Pablo
    Flisser, Ana
    Ostrosky-Wegman, Patricia
    Mendlovic, Fela
    VIRAL IMMUNOLOGY, 2023, 36 (08) : 550 - 561
  • [5] Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
    Hiki, Makoto
    Tabe, Yoko
    Ai, Tomohiko
    Matsue, Yuya
    Harada, Norihiro
    Sugimoto, Kiichi
    Matsushita, Yasushi
    Matsushita, Masakazu
    Wakita, Mitsuru
    Misawa, Shigeki
    Idei, Mayumi
    Miida, Takashi
    Tamura, Naoto
    Takahashi, Kazuhisa
    Naito, Toshio
    PLOS ONE, 2021, 16 (04):
  • [6] Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
    Huynh, Angela
    Arnold, Donald M.
    Smith, James W.
    Moore, Jane C.
    Zhang, Ali
    Chagla, Zain
    Harvey, Bart J.
    Stacey, Hannah D.
    Ang, Jann C.
    Clare, Rumi
    Ivetic, Nikola
    Chetty, Vasudhevan T.
    Bowdish, Dawn M. E.
    Miller, Matthew S.
    Kelton, John G.
    Nazy, Ishac
    VIRUSES-BASEL, 2021, 13 (04):
  • [7] Anti-SARS-COV-2 and self-reactive antibodies in neuropsychiatric COVID-19
    Bartley, Christopher
    Ngo, Thomas
    Dandekar, Ravi
    Song, Eric
    Alvarenga, Bonny
    Johns, Claire
    Wietstock, Sharon
    Zamecnik, Colin
    Rajan, Jayant
    Derisi, Joseph
    Spudich, Serena
    Farhadian, Shelli
    Pleasure, Samuel
    Wilson, Michael
    CHEMICAL SENSES, 2022, 47
  • [8] Seroprevalence of Anti-SARS-CoV-2 Antibodies in COVID-19 Patients in Hyderabad, Sindh
    Qureshi, Shahzad Rasheed
    Memon, Nazakat Hussain
    Arain, Sadia Qamar
    Nizamani, Ghulam Shah
    Abbasi, Majid Ali
    Laghari, Arshad Hussain
    Rajput, Ali Raza
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (56B) : 8 - 14
  • [9] Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management
    Li, Jonathan Z.
    Gandhi, Rajesh T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (05): : 427 - 429
  • [10] DATA ON ANTI-SARS-COV-2 ANTIBODIES (IGM/IGG) IN COVID-19 PATIENTS
    Coculescu, Bogdan-Ioan
    Pana, Marina
    Vladimirescu, Alexandru Filip
    Coculescu, Elena Claudia
    Popa, Mircea-loan
    ROMANIAN JOURNAL OF LEGAL MEDICINE, 2021, 29 (04): : 356 - 359
12345